Clinical trialNCT00003170CompletedPhase 3Interventional

Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer

SponsorAlliance for Clinical Trials in OncologyEnrollment129Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Glutamine may be an effective treatment for acute diarrhea caused by radiation therapy. It is not known if glutamine is an effective treatment for acute diarrhea caused by radiation therapy. PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of glutamine in preventing acute diarrhea in patients who have pelvic cancer and who are receiving radiation therapy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Timothy F. Kozelsky, MD
Mayo Clinic
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Saskatchewan Cancer Agency
Regina, Saskatchewan, Canada

United States

Ccop - Scottsdale Oncology Program
Scottsdale, Arizona, United States
Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
Ccop - Carle Cancer Center
Urbana, Illinois, United States
Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
Siouxland Hematology-Oncology
Sioux City, Iowa, United States
Ccop - Wichita
Wichita, Kansas, United States
Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
Ccop - Duluth
Duluth, Minnesota, United States
Mayo Clinic Cancer Center
Rochester, Minnesota, United States
Centracare Clinic
Saint Cloud, Minnesota, United States
Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
Quain & Ramstad Clinic, P.C.
Bismarck, North Dakota, United States
Ccop - Merit Care Hospital
Fargo, North Dakota, United States
Ccop - Toledo Community Hospital Oncology Program
Toledo, Ohio, United States
Ccop - Geisinger Clinical and Medical Center
Danville, Pennsylvania, United States
Ccop - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Feb 1998
Primary completion: 31 May 2003
Completion: 30 Jun 2003
Last update posted: 14 Jul 2016
Registered enrollment: 129
Registry id: NCT00003170

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.